Literature DB >> 21632754

Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.

Sara Gianella1, Wayne Delport, Mary E Pacold, Jason A Young, Jun Yong Choi, Susan J Little, Douglas D Richman, Sergei L Kosakovsky Pond, Davey M Smith.   

Abstract

Reports of a high frequency of the transmission of minority viral populations with drug-resistant mutations (DRM) are inconsistent with evidence that HIV-1 infections usually arise from mono- or oligoclonal transmission. We performed ultradeep sequencing (UDS) of partial HIV-1 gag, pol, and env genes from 32 recently infected individuals. We then evaluated overall and per-site diversity levels, selective pressure, sequence reproducibility, and presence of DRM and accessory mutations (AM). To differentiate biologically meaningful mutations from those caused by methodological errors, we obtained multinomial confidence intervals (CI) for the proportion of DRM at each site and fitted a binomial mixture model to determine background error rates for each sample. We then examined the association between detected minority DRM and the virologic failure of first-line antiretroviral therapy (ART). Similar to other studies, we observed increased detection of DRM at low frequencies (average, 0.56%; 95% CI, 0.43 to 0.69; expected UDS error, 0.21 ± 0.08% mutations/site). For 8 duplicate runs, there was variability in the proportions of minority DRM. There was no indication of increased diversity or selection at DRM sites compared to other sites and no association between minority DRM and AM. There was no correlation between detected minority DRM and clinical failure of first-line ART. It is unlikely that minority viral variants harboring DRM are transmitted and maintained in the recipient host. The majority of low-frequency DRM detected using UDS are likely errors inherent to UDS methodology or a consequence of error-prone HIV-1 replication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632754      PMCID: PMC3147985          DOI: 10.1128/JVI.02582-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

Review 1.  Minority variants of drug-resistant HIV.

Authors:  Sara Gianella; Douglas D Richman
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

2.  Increased detection of HIV-1 drug resistance at time of diagnosis by testing viral DNA with a sensitive assay.

Authors:  Giovanina M Ellis; Libby C Page; Blaire E Burman; Susan Buskin; Lisa M Frenkel
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

3.  Base-calling of automated sequencer traces using phred. I. Accuracy assessment.

Authors:  B Ewing; L Hillier; M C Wendl; P Green
Journal:  Genome Res       Date:  1998-03       Impact factor: 9.043

Review 4.  Modeling sequence evolution in acute HIV-1 infection.

Authors:  Ha Youn Lee; Elena E Giorgi; Brandon F Keele; Brian Gaschen; Gayathri S Athreya; Jesus F Salazar-Gonzalez; Kimmy T Pham; Paul A Goepfert; J Michael Kilby; Michael S Saag; Eric L Delwart; Michael P Busch; Beatrice H Hahn; George M Shaw; Bette T Korber; Tanmoy Bhattacharya; Alan S Perelson
Journal:  J Theor Biol       Date:  2009-08-04       Impact factor: 2.691

5.  Detection of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infection.

Authors:  Thomas A Toni; Eugene L Asahchop; Daniela Moisi; Michel Ntemgwa; Maureen Oliveira; Bernard Masquelier; Bluma G Brenner; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

6.  Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation.

Authors:  Vici Varghese; Elijah Wang; Farbod Babrzadeh; Michael H Bachmann; Rajin Shahriar; Tommy Liu; Svetlana Jean M Mappala; Baback Gharizadeh; W Jeffrey Fessel; David Katzenstein; Seble Kassaye; Robert W Shafer
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

7.  High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.

Authors:  Hui Li; Katharine J Bar; Shuyi Wang; Julie M Decker; Yalu Chen; Chuanxi Sun; Jesus F Salazar-Gonzalez; Maria G Salazar; Gerald H Learn; Charity J Morgan; Joseph E Schumacher; Peter Hraber; Elena E Giorgi; Tanmoy Bhattacharya; Bette T Korber; Alan S Perelson; Joseph J Eron; Myron S Cohen; Charles B Hicks; Barton F Haynes; Martin Markowitz; Brandon F Keele; Beatrice H Hahn; George M Shaw
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

8.  Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study.

Authors:  Max Lataillade; Jennifer Chiarella; Rong Yang; Steven Schnittman; Victoria Wirtz; Jonathan Uy; Daniel Seekins; Mark Krystal; Marco Mancini; Donnie McGrath; Birgitte Simen; Michael Egholm; Michael Kozal
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

9.  Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants.

Authors:  M-R Abrahams; J A Anderson; E E Giorgi; C Seoighe; K Mlisana; L-H Ping; G S Athreya; F K Treurnicht; B F Keele; N Wood; J F Salazar-Gonzalez; T Bhattacharya; H Chu; I Hoffman; S Galvin; C Mapanje; P Kazembe; R Thebus; S Fiscus; W Hide; M S Cohen; S Abdool Karim; B F Haynes; G M Shaw; B H Hahn; B T Korber; R Swanstrom; C Williamson
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

10.  Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing.

Authors:  Will Fischer; Vitaly V Ganusov; Elena E Giorgi; Peter T Hraber; Brandon F Keele; Thomas Leitner; Cliff S Han; Cheryl D Gleasner; Lance Green; Chien-Chi Lo; Ambarish Nag; Timothy C Wallstrom; Shuyi Wang; Andrew J McMichael; Barton F Haynes; Beatrice H Hahn; Alan S Perelson; Persephone Borrow; George M Shaw; Tanmoy Bhattacharya; Bette T Korber
Journal:  PLoS One       Date:  2010-08-20       Impact factor: 3.240

View more
  50 in total

Review 1.  New virologic tools for management of chronic hepatitis B and C.

Authors:  Stéphane Chevaliez; Christophe Rodriguez; Jean-Michel Pawlotsky
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

2.  Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.

Authors:  Antoine Chaillon; Gabriel A Wagner; N Lance Hepler; Susan J Little; Sergei L Kosakovsky Pond; Gemma Caballero; Mary E Pacold; Pham Phung; Terri Wrin; Douglas D Richman; Joel O Wertheim; Davey M Smith
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

3.  Using ultradeep pyrosequencing to study HIV-1 coreceptor usage in primary and dual infection.

Authors:  Gabriel A Wagner; Mary E Pacold; Edgar Vigil; Gemma Caballero; Sheldon R Morris; Sergei L Kosakovsky Pond; Susan J Little; Douglas D Richman; Sara Gianella; Davey M Smith
Journal:  J Infect Dis       Date:  2013-04-18       Impact factor: 5.226

4.  Detection of HIV-1 minority variants containing the K103N drug-resistance mutation using a simple method to amplify RNA targets (SMART).

Authors:  Kenneth Morabito; Rami Kantor; Warren Tai; Leeann Schreier; Anubhav Tripathi
Journal:  J Mol Diagn       Date:  2013-03-29       Impact factor: 5.568

5.  Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencing.

Authors:  Ingrid A Beck; Wenjie Deng; Rachel Payant; Robert Hall; Roger E Bumgarner; James I Mullins; Lisa M Frenkel
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

6.  Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.

Authors:  Antoine Chaillon; Sara Gianella; Steven M Lada; Josué Perez-Santiago; Parris Jordan; Caroline Ignacio; Maile Karris; Douglas D Richman; Sanjay R Mehta; Susan J Little; Joel O Wertheim; Davey M Smith
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

7.  A case cluster demonstrating the relationship between HLA concordance and virologic and disease outcomes in human immunodeficiency virus infection.

Authors:  A Chaillon; S Gianella; M Massanella Luna; S J Little; D D Richman; S R Mehta
Journal:  Virology       Date:  2013-11-27       Impact factor: 3.616

8.  Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing.

Authors:  Philip L Tzou; Pramila Ariyaratne; Vici Varghese; Charlie Lee; Elian Rakhmanaliev; Carolin Villy; Meiqi Yee; Kevin Tan; Gerd Michel; Benjamin A Pinsky; Robert W Shafer
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

9.  Clinical implications of HIV-1 minority variants.

Authors:  Jonathan Z Li; Daniel R Kuritzkes
Journal:  Clin Infect Dis       Date:  2013-02-27       Impact factor: 9.079

10.  Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells.

Authors:  Sara Gianella; Sanjay R Mehta; Jason A Young; Milenka V Vargas; Susan J Little; Douglas D Richman; Sergei L Kosakovsky Pond; Davey M Smith
Journal:  Virology       Date:  2012-10-03       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.